Q4 2021 Evofem Biosciences Inc Earnings Call Transcript
Thank you for standing by, and welcome to the Evofem Biosciences Fourth Quarter and Year-end 2021 Results Conference Call. (Operator Instructions) As a reminder today's conference call is being recorded.
I would now like to turn the conference over to your host, Ms. Amy Raskopf, Vice President of Investor Relations. Ma'am, you may begin.
Thank you, Valerie. Good afternoon, everyone, and welcome to the Evofem Biosciences Q4 and Year-end 2021 Results Call. If you haven't done so already, I encourage you to access the press release we issued this afternoon and slides accompanying this call, both of which are at evofem.com under the Investors tab.
Before we begin, I would like to remind you that remarks made on this call will contain forward-looking statements, which are made only as of today, March 3, 2022. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |